score,metric,date,value,year,sentence,number
0.7456533908843994,marketable securities,"december 31, 2021",$7.6 billion,2021,"as of december 31, 2021, cash, cash equivalents, and marketable securities held by foreign subsidiaries were $7.6 billion",7600000000.0
0.6476994752883911,marketable securities,2021,$11.8 billion,2021,"included in other income (expense), net in 2021 is a valuation gain of $11.8 billion from our equity securities of rivian automotive, inc., which completed an initial public offering in november 2021.",11800000000.0
0.6012738347053528,marketable securities,2021,$260 million,2021,"as of december 31, 2020 and 2021, restricted cash, cash equivalents, and marketable securities were $257 million and $260 million",260000000.0
0.5335068106651306,marketable securities,2021,$11.8 billion,2021,"included in other income (expense), net in 2021 is a marketable equity securities valuation gain of $11.8 billion from our equity investment in rivian automotive, inc",11800000000.0
0.3826120793819427,marketable securities,2021,$96.0 billion,2021,"our principal sources of liquidity are cash flows generated from operations and our cash, cash equivalents, and marketable securities balances, which, at fair value, were $84.4 billion and $96.0 billion as of december 31, 2020 and 2021",96000000000.0
0.3075807988643646,marketable securities,"december 31, 2020 and",$84.4 billion,2020,"our principal sources of liquidity are cash flows generated from operations and our cash, cash equivalents, and marketable securities balances, which, at fair value, were $84.4 billion and $96.0 billion as of december 31, 2020 and 2021",84400000000.0
0.1423781365156173,r&d value,2020,$1.1 billion,2020,"during 2020, we acquired certain companies for an aggregate purchase price of $1.2 billion, net of cash acquired, of which $1.1 billion was capitalized to in-process research and development intangible assets (“ipr&d”).",1100000000.0
